Cardiac Complications in Patients Hospitalised With COVID-19 in Australia

Autor: Anthony Delaney, Sheran Vasanthakumar, C. Choong, John Zhu, Brendan McQuillan, William Wilson, Sidney Lo, Andy S.C. Yong, William J. van Gaal, Logan Kanagaratnam, Hari P Sritharan, Ravinay Bhindi, Daniel Nour, James C. Weaver, Clara K Chow, Nigel Jepson, George Javorsky, Rohan Bhagwandeen, Leonard Kritharides, David Brieger, Isuru Ranasinghe, Andrew I. MacIsaac, Kunwardeep S Bhatia, Antony Walton, Benjamin Harris, Jonathan L Ciofani, P. Jayadeva, Graham S. Hillis, Justin Chia, Bernard J Hudson, Girish Dwivedi, Karina Chui, Dhanvee Kandadai, Usaid K. Allahwala, Astin Lee, George Kotsiou
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Heart, Lung & Circulation
ISSN: 1444-2892
1443-9506
Popis: OBJECTIVES: Describe the incidence of cardiac complications in patients admitted to hospital with COVID-19 in Australia. DESIGN: Observational cohort study. SETTING: Twenty-one (21) Australian hospitals. PARTICIPANTS: Consecutive patients aged ≥18 years admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. MAIN OUTCOME MEASURES: Incidence of cardiac complications. RESULTS: Six-hundred-and-forty-four (644) hospitalised patients (62.5±20.1 yo, 51.1% male) with COVID-19 were enrolled in the study. Overall in-hospital mortality was 14.3%. Twenty (20) (3.6%) patients developed new atrial fibrillation or flutter during admission and 9 (1.6%) patients were diagnosed with new heart failure or cardiomyopathy. Three (3) (0.5%) patients developed high grade atrioventricular (AV) block. Two (2) (0.3%) patients were clinically diagnosed with pericarditis or myopericarditis. Among the 295 (45.8%) patients with at least one troponin measurement, 99 (33.6%) had a peak troponin above the upper limit of normal (ULN). In-hospital mortality was higher in patients with raised troponin (32.3% vs 6.1%, p
Databáze: OpenAIRE
Externí odkaz: